Youth Bio Global Co., Ltd.

Youth Bio Global Co., Ltd. specializes in exudate-absorbent dressings specifically designed as hydrophilic-gel, non-antimicrobial products. These dressings are intended to manage wound exudate by maintaining a moist environment to support healing, particularly for wounds requiring controlled moisture balance.

The company is headquartered in the United States. This location influences its regulatory compliance and distribution networks, particularly for markets like the U.S., where its devices may be subject to FDA oversight.

Youth Bio Global Co., Ltd.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is critical for tracking and transparency in the U.S. medical device market, ensuring traceability and compliance with regulatory requirements.

The company’s products fall under Class I medical device classification. This classification is typically assigned to devices posing minimal risk to patients, such as certain wound care items, which often require less stringent premarket review compared to higher-risk categories.